+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 100 Pages
  • Global
From
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 157 Pages
  • Global
From
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups

  • Report
  • May 2024
  • 50 Pages
  • Canada
The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - UK Edition - The Views of 87 UK Patient Groups

  • Report
  • May 2024
  • 59 Pages
  • United Kingdom
Onychomycosis Market Report 2025 - Product Thumbnail Image

Onychomycosis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Subcutaneous Immunoglobulin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Subcutaneous Immunoglobulin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Finland Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Finland Pharmaceutical - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 80 Pages
  • Finland
From
Meningococcal Vaccines Market Report and Forecast 2024-2032 - Product Thumbnail Image

Meningococcal Vaccines Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Travel Vaccines Market Report and Forecast 2024-2032 - Product Thumbnail Image

Travel Vaccines Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Interferons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Interferons - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 110 Pages
  • Global
From
Pneumococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Interleukin Inhibitors Market Report 2025 - Product Thumbnail Image

Interleukin Inhibitors Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • September 2022
  • 176 Pages
  • Global
From
Ear Infection Market Report 2025 - Product Thumbnail Image

Ear Infection Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Nontuberculous Mycobacterial Infection Market Report 2025 - Product Thumbnail Image

Nontuberculous Mycobacterial Infection Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Diphtheria Market Report 2025 - Product Thumbnail Image

Diphtheria Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Aspergillosis Treatment Market Report 2025 - Product Thumbnail Image

Aspergillosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Encephalitis Treatment Market Report 2025 - Product Thumbnail Image

Encephalitis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Loading Indicator